BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 18, Issue 5
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. May 15, 2026; 18(5): 117512
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.117512
Figure 3
Full Size Figure Download Figure
Figure 3 Cumulative incidence of hepatocellular carcinoma by change in fibrosis-4 group. Increase [change in fibrosis-4 (FIB-4) ≥ +1.0], decrease (ΔFIB-4 ≤ -1.0), stable (-1.0 < ΔFIB-4 < +1.0). The 5-, 10-, and 15-year cumulative incidence of hepatocellular carcinoma was 4.4%, 29.9%, and 72.7% for increase group; 9.2%, 30.7%, and 35.7% for decrease group; and 0%, 12.1%, and 27.1% for stable group, respectively.
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.